| Date | Time | Source | Headline | Symbol | Company |
| 04/25/2008 | 4:11PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 04/25/2008 | 4:11PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 04/25/2008 | 4:11PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 04/25/2008 | 4:11PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 04/22/2008 | 4:35PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 03/14/2008 | 4:12PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 03/14/2008 | 4:08PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Proxy Statement (definitive) (DEF 14A) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 03/11/2008 | 5:18PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Annual Report (10-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 03/06/2008 | 4:14PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/20/2008 | 4:00PM | PR Newswire (US) | Lexicon to Report Fourth Quarter and Full Year 2007 Financial Results on March 6, 2008 | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/13/2008 | 4:43PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:06PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/11/2008 | 6:05PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 02/01/2008 | 4:12PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Amended Statement of Ownership (SC 13G/A) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 01/22/2008 | 2:23PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Amended Statement of Ownership (SC 13G/A) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 01/07/2008 | 4:16PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Current report filing (8-K) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 01/03/2008 | 6:30AM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at the 26th Annual JPMorgan Healthcare Conference | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 12/21/2007 | 6:30AM | PR Newswire (US) | Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 12/20/2007 | 4:28PM | Edgar (US Regulatory) | Lexicon Pharmaceuticals, Inc./De - Statement of Changes in Beneficial Ownership (4) | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 12/10/2007 | 6:30AM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 12/05/2007 | 6:30AM | PR Newswire (US) | Lexicon Initiates Phase 2a Trial of LX6171 Drug Candidate for Cognitive Disorders | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 12/03/2007 | 8:00AM | PR Newswire (US) | Lexicon Pharmaceuticals Research and Development Day Webcast | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |
| 11/26/2007 | 4:15PM | PR Newswire (US) | Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference | NASDAQ:LXRX | Lexicon Pharmaceuticals Inc |